Status:
COMPLETED
Southeast Asian Women's Health Project
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
University of South Florida
American Cancer Society, Inc.
Conditions:
Breast Cancer
Cervical Cancer
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
Cancer is the leading cause of death for Southeast Asian refugee and immigrant (R/I) women; yet they have unacceptably low screening rates. Drawing on successful tailored navigation interventions, the...
Detailed Description
Cancer is the leading cause of death for Southeast Asian refugee and immigrant women. Cambodian, Lao, and Vietnamese (hereafter referred to as SEAR/I) women have disproportionately high incidence rate...
Eligibility Criteria
Inclusion
- Live in Ohio
- Self-identify as Filipino, Cambodian, Lao, or Vietnamese
- Aged 21 years and older
- Non-adherent for mammogram, Pap test, or both
- Have a mother or daughter aged 21 years and older.
- If potential participants do not have a mother or daughter, then they would have to have an immediate female family member, such as an aunt, niece, or grandmother aged 21 years and older who could also be recruited into the study.
Exclusion
- Women who have been previously diagnosed with breast and/or cervical cancer.
- Siblings such as a sister will not be considered eligible unless they are from different generations.
Key Trial Info
Start Date :
October 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT04086771
Start Date
October 16 2020
End Date
August 30 2024
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210